1Cimbaluk D, Rotmensch J, Scudiere J,et al. Uterine studies on tissue microarrays with focus on potential therapeutic targets [ J ]. Gynecol Oncol, 2007,105 ( 1 ) : 138-144.
2Pardo J, Aisa G, Alava ED, et al. Primary mixed squamous carci-noma and osteosarcom(carcinosarcoraas) of the lung have a CGH mapping similar to primitive squamous carcinomas and osteosarco- mas [ J ]. Diagn Mol Pathol,2008,17 (3) : 151-158.
3Armstrong AB, Wang M, Eble JN, et al. TP53 mutation alanalysis supports monoclonal origin of biphasic sarcomatoid urothelial carci- noma (careinosarcoma) of the urinary bladder [ J ]. 2009,22(1) :113-118.
4Garg G, Shah JP, Kumar S, et al. Ovarian and uterine Mod Pathol mas:a comparative analysis of prognostic variables and survival outcomes[ J]. Int J Gynecol Cancer,2010,20 (5) :888-894.
5Bansal N, Herzoq TJ, Seshan VE, et al. Uterine carcinosarcomas and grade 3 endometrioid cancers evidence for distinct tumor behavior[J]. Bosket Gyneeo1,2008,112 ( 1 ) :64-70.
6Kuyumcuoglu U, Kale A. Homologous type of malignant mixed Mullerian tumor of the uterus presenting as a cervical mass [ J ]. J Chin Med Assoc,2009,72(10) :533-535.
7Arora P, Ran S, Khurana N, et al. Malignant mixed Mullerian tumor of broad ligament with synchronous ovarian and endometrial carci- noma: a rare association [ J ]. J Cancer Res Ther, 2011,7 ( 1 ) : 88-91.
8Kato H, Kanematsu M, Furui T, et al. C of the ute- rus : radiologie-pathologic correlations with magnetic resonance ima- ging including diffusion- weighted imaging [ J ]. Magn Reson Ima- ging,2008,26 (10) : 1446-1450.
9Gonzalea Bosquet J, Terstriep SA, Clihy WA, et al. The impact of multi-modal therapy on survival for uterine carcinosarcoma [ J ]. Gvnecol Oncol.2010.116 ( 3 ) :419-423.
10Tanaka YO, Tsunoda H, Minami R, et al. Carcinosarcoma of the uterus : MR findings [ J ]. J Magn Reson Imaging, 2008,28 ( 2 ) : 434-439.
